Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource and expertise. Our mission is to accelerate the discovery of new medicines from the laboratory into development to treat patients with a range of debilitating and fatal diseases.
Sygnature adds significant value to collaborations by providing advanced scientific knowledge and intellectual input to accelerate your drug discovery projects from target validation through to pre-clinical candidate. We have an enviable track record of success for our clients. There are currently 9 drug candidates in the clinic, invented at Sygnature.
Multi-award winning Sygnature Discovery operates from the brand new £30m Discovery Building where over 150 experienced research scientists take on board the most demanding of drug discovery programmes and drive them towards a successful outcome.
Don’t hesitate to get in touch with us to discuss your project requirements - even if your idea is still very early stage we can offer help and guidance to set you on the path to success.